Precision Matters: Repeatability and Reproducibility of Total PSA and Homocysteine Measurements in Alinity i-System
Abstract
Introduction: The precision of test measurements is critical in clinical diagnostics, especially for biomarkers like total PSA and homocysteine, which are essential to disease assessment. Using the CMIA approach, this study investigates the repeatability and reproducibility of these biomarkers on the Abbott Alinity system.
Materials and methods: The present study was conducted in the clinical chemistry laboratory at Mohammed VI University Hospital of Oujda. The evaluation of the Alinity i-system's analytical performance for total PSA and homocysteine focused on assessing repeatability and intermediate fidelity. The assessment followed the protocols and guidelines established by the French Society of Clinical Biology (SFBC).
Results: Our analysis yielded favorable findings regarding the performance of the Alinity assays. The coefficients of variation for both the intra-assay and inter-assay precision were less than 5.89% and 4.29%, respectively. These findings underscore the tests' precision and consistency, affirming the CMIA method's reliability in accurately measuring total PSA and homocysteine levels.
Conclusion: Our assessment of the Alinity i-system for total PSA and homocysteines showed significant analytical performance. Yet, limitations due to excluding critical parameters hindered a comprehensive evaluation. Addressing these in future investigations is crucial for upholding high diagnostic standards.
Copyright (c) 2024 Oussama Grari
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.